HER2 and ABCC1 are identified as significant transcriptomic predictors of overall survival in patients treated with T-DXd. A large-scale analysis reveals novel predictors of survival and resistance ...

The Global Oncology Companion Diagnostic Market presents opportunities driven by rising cancer incidences and demand for personalized medicine. Growth is fueled by precision oncology's shift to ...

The Joseph Fraser Memorial Hospital Trust (JFMH Trust), a registered non-profit charity in Sri Lanka, has pledged its support to strengthen and modernize histopathology services at the University of ...

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

A new nanobody-based method, POD-nAb/FT-GO 3D-IHC, enables ultra-fast, high-resolution labeling of neurons and glia deep within 1-mm-thick brain tissue, revealing cellular structures in just three ...

Caris Life Sciences aims to standardize MET immunohistochemistry testing for non-squamous non-small cell lung cancer to enhance molecular insights and treatment personalization. MET protein expression ...

Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases. Immunophenotyping is a lab test doctors use to identify and ...

The global Immunohistochemistry market size was valued at USD 3.19 billion in 2023 and is poised to exceed USD 5.66 billion by 2033, expanding at a CAGR of 5.9% between 2024 and 2033. The global ...

Researchers have used immunohistochemistry (IHC) for decades, and the technique has continually evolved alongside technological and scientific advances. Even now, scientists constantly modify and ...

Immunohistochemistry (IHC) has continually evolved alongside technological and scientific advances. Because scientists constantly develop and modify their IHC techniques to better answer modern ...